Clinical trial
Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors
NCT02600156 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT02600156 |
|---|---|
| Title | Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors |
| Official title | A Pilot Study to Evaluate Magnetic Resonance Thermal Image-Guided Focal Laser Ablation of Prostate Cancer Tumors |
| Lead sponsor | Mayo Clinic, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Prostate Cancer, Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Localized Prostate Carcinoma |
| Intervention type | Procedure |
| Interventions | Focal laser ablation of the prostate |
| Enrollment | 7 |
| Start date | Sep 1, 2015 |
| Primary completion | Aug 20, 2025 |
| Completion | Dec 9, 2025 |
| First posted | Nov 9, 2015 |
| Last update posted | Dec 17, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: